We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
RPL38
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • RPL38
CANCER UROTHELIAL CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
BLCA TCGA PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Urothelial cancer
Human cancer
Bladder urothelial carcinoma
BLADDER UROTHELIAL CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

RPL38 is not prognostic in Bladder Urothelial Carcinoma (TCGA)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 1620.49
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 2239.8
Number of samples 169
Samples
Sample Description pTPM
TCGA-C4-A0F7-01A 77 years, male, stage:Stage IV, dead, 62 days 10526.0
TCGA-XF-AAMH-01A 80 years, male, white, stage:Stage IV, dead, 344 days 5437.6
TCGA-XF-A9ST-01A 68 years, male, white, stage:Stage III, dead, 128 days 4683.9
TCGA-FD-A3B4-01A 55 years, female, black or african american, stage:Stage III, dead, 510 days 4552.2
TCGA-UY-A78N-01A 80 years, male, white, stage:Stage IV, dead, 2641 days 4508.5
TCGA-FJ-A3ZE-01A 65 years, male, white, stage:Stage IV, dead, 324 days 4425.6
TCGA-BT-A0S7-01A 75 years, male, white, stage:Stage III, dead, 200 days 4420.9
TCGA-ZF-AA4N-01A 74 years, male, white, stage:Stage II, dead, 88 days 4334.7
TCGA-XF-A9SH-01A 65 years, female, asian, stage:Stage II, dead, 1971 days 4047.1
TCGA-XF-A8HF-01A 80 years, male, white, stage:Stage III, dead, 2954 days 3967.3
TCGA-CF-A47T-01A 58 years, female, asian, stage:Stage II, dead, 385 days 3848.8
TCGA-FD-A6TF-01A 80 years, female, white, stage:Stage IV, dead, 69 days 3785.2
TCGA-FJ-A871-01A 49 years, male, white, stage:Stage III, dead, 272 days 3737.1
TCGA-UY-A78M-01A 81 years, female, asian, stage:Stage IV, dead, 690 days 3715.1
TCGA-FD-A43Y-01A 65 years, male, white, stage:Stage III, dead, 474 days 3634.5
TCGA-DK-AA6W-01A 78 years, male, white, stage:Stage II, dead, 415 days 3545.6
TCGA-C4-A0EZ-01A 69 years, female, stage:Stage IV, dead, 273 days 3525.0
TCGA-DK-AA75-01A 82 years, male, white, stage:Stage III, dead, 340 days 3455.1
TCGA-XF-A8HG-01A 69 years, male, white, stage:Stage III, dead, 467 days 3453.1
TCGA-BT-A20J-01A 75 years, male, white, stage:Stage II, dead, 579 days 3445.3
TCGA-ZF-A9R3-01A 53 years, female, white, stage:Stage II, dead, 949 days 3425.2
TCGA-4Z-AA7Q-01A 79 years, male, white, stage:Stage III, dead, 510 days 3224.5
TCGA-FD-A6TD-01A 77 years, male, white, stage:Stage III, dead, 386 days 3157.3
TCGA-ZF-AA5N-01A 62 years, female, white, stage:Stage IV, dead, 168 days 3109.1
TCGA-XF-A8HC-01A 79 years, male, asian, stage:Stage IV, dead, 200 days 3076.3
TCGA-2F-A9KO-01A 63 years, male, white, stage:Stage IV, dead, 734 days 3065.7
TCGA-FD-A62O-01A 74 years, male, white, stage:Stage IV, dead, 216 days 3047.5
TCGA-GU-AATQ-01A 68 years, male, white, stage:Stage III, dead, 213 days 3044.2
TCGA-HQ-A5ND-01A 78 years, male, stage:Stage IV, dead, 274 days 3030.6
TCGA-K4-A5RI-01A 67 years, female, white, stage:Stage III, dead, 356 days 2997.2
TCGA-ZF-A9RD-01A 75 years, female, white, stage:Stage IV, dead, 408 days 2960.9
TCGA-GV-A3JV-01A 66 years, male, white, stage:Stage IV, dead, 434 days 2871.5
TCGA-XF-AAMW-01A 79 years, female, white, stage:Stage IV, dead, 253 days 2862.3
TCGA-BT-A20W-01A 71 years, male, white, stage:Stage II, dead, 254 days 2848.9
TCGA-4Z-AA82-01A 59 years, male, black or african american, stage:Stage IV, dead, 1556 days 2840.9
TCGA-E7-A4XJ-01A 66 years, male, asian, stage:Stage II, dead, 68 days 2815.7
TCGA-BT-A20N-01A 72 years, male, stage:Stage III, dead, 795 days 2782.0
TCGA-GU-A42Q-01A 67 years, male, white, stage:Stage III, dead, 344 days 2776.4
TCGA-GU-A762-01A 87 years, male, white, stage:Stage IV, dead, 232 days 2762.9
TCGA-DK-AA6Q-01A 61 years, female, white, stage:Stage IV, dead, 413 days 2741.3
TCGA-BL-A13J-01A 65 years, male, white, stage:Stage IV, dead, 81 days 2711.5
TCGA-FD-A6TH-01A 63 years, male, white, stage:Stage IV, dead, 131 days 2693.1
TCGA-ZF-A9RN-01A 67 years, female, white, stage:Stage III, dead, 615 days 2690.4
TCGA-FD-A5BV-01A 47 years, female, white, stage:Stage III, dead, 163 days 2645.5
TCGA-XF-AAML-01A 75 years, male, white, stage:Stage II, dead, 232 days 2624.1
TCGA-BT-A20X-01A 56 years, male, white, stage:Stage IV, dead, 251 days 2583.4
TCGA-5N-A9KI-01A 76 years, female, white, stage:Stage III, dead, 76 days 2566.3
TCGA-FD-A5BX-01A 82 years, male, white, stage:Stage IV, dead, 173 days 2565.2
TCGA-XF-AAN2-01A 73 years, male, white, stage:Stage II, dead, 1869 days 2560.8
TCGA-XF-A8HH-01A 61 years, female, white, stage:Stage IV, dead, 57 days 2547.1
TCGA-2F-A9KP-01A 66 years, male, white, stage:Stage IV, dead, 364 days 2536.6
TCGA-XF-AAN8-01A 74 years, female, white, stage:Stage III, dead, 118 days 2517.3
TCGA-4Z-AA86-01A 66 years, male, black or african american, stage:Stage IV, dead, 311 days 2508.6
TCGA-S5-A6DX-01A 83 years, male, white, stage:Stage IV, dead, 56 days 2482.1
TCGA-GC-A3BM-01A 70 years, male, white, stage:Stage II, dead, 651 days 2473.5
TCGA-FD-A3SJ-01A 59 years, male, white, stage:Stage IV, dead, 739 days 2471.3
TCGA-5N-A9KM-01A 73 years, female, white, stage:Stage III, dead, 530 days 2432.9
TCGA-GV-A3QH-01A 67 years, male, white, stage:Stage II, dead, 258 days 2413.8
TCGA-DK-A2I2-01A 63 years, female, white, stage:Stage IV, dead, 237 days 2407.5
TCGA-XF-AAN1-01A 75 years, female, stage:Stage III, dead, 941 days 2401.1
TCGA-GV-A3QF-01A 79 years, male, white, stage:Stage IV, dead, 617 days 2397.7
TCGA-BT-A3PK-01A 80 years, male, white, stage:Stage II, dead, 303 days 2382.2
TCGA-G2-A2EO-01A 69 years, male, white, stage:Stage III, dead, 1804 days 2365.4
TCGA-CU-A5W6-01A 70 years, male, white, stage:Stage III, dead, 56 days 2357.9
TCGA-DK-A3IQ-01A 74 years, male, white, stage:Stage III, dead, 539 days 2349.0
TCGA-XF-AAN0-01A 68 years, male, white, stage:Stage IV, dead, 1718 days 2334.7
TCGA-UY-A78K-01A 60 years, male, white, stage:Stage IV, dead, 536 days 2323.7
TCGA-ZF-AA4U-01A 70 years, male, white, stage:Stage III, dead, 262 days 2297.2
TCGA-BT-A20Q-01A 73 years, male, white, stage:Stage IV, dead, 593 days 2293.3
TCGA-G2-AA3C-01A 66 years, male, white, stage:Stage IV, dead, 211 days 2283.8
TCGA-DK-A3IM-01A 76 years, male, white, stage:Stage III, dead, 248 days 2265.3
TCGA-FD-A3B7-01A 66 years, male, black or african american, stage:Stage III, dead, 122 days 2253.8
TCGA-2F-A9KW-01A 67 years, female, white, stage:Stage III, dead, 254 days 2251.3
TCGA-DK-A1A3-01A 60 years, male, white, stage:Stage IV, dead, 665 days 2244.3
TCGA-CU-A0YN-01A 60 years, male, white, stage:Stage III, dead, 393 days 2229.6
TCGA-G2-A2ES-01A 85 years, male, white, stage:Stage II, dead, 1004 days 2220.4
TCGA-XF-A9SU-01A 74 years, female, white, stage:Stage IV, dead, 182 days 2207.1
TCGA-ZF-AA56-01A 79 years, female, white, stage:Stage III, dead, 259 days 2187.3
TCGA-BT-A20V-01A 59 years, female, black or african american, stage:Stage IV, dead, 154 days 2177.5
TCGA-2F-A9KR-01A 59 years, female, stage:Stage III, dead, 3183 days 2175.8
TCGA-XF-A9SP-01A 59 years, male, white, stage:Stage III, dead, 454 days 2143.6
TCGA-G2-A2EC-01A 58 years, female, black or african american, stage:Stage II, dead, 696 days 2120.0
TCGA-XF-AAMT-01A 75 years, female, white, stage:Stage IV, dead, 90 days 2111.4
TCGA-FJ-A3Z9-01A 72 years, male, white, stage:'--, dead, 385 days 2111.4
TCGA-4Z-AA7N-01A 65 years, male, white, stage:Stage III, dead, 1367 days 2096.6
TCGA-FD-A3B5-01A 86 years, male, black or african american, stage:Stage IV, dead, 272 days 2093.3
TCGA-XF-A9SZ-01A 79 years, male, white, stage:Stage IV, dead, 859 days 2086.4
TCGA-GV-A40E-01A 75 years, male, white, stage:Stage II, dead, 261 days 2067.3
TCGA-BT-A20P-01A 81 years, female, white, stage:Stage III, dead, 544 days 2046.4
TCGA-ZF-AA54-01A 71 years, male, white, stage:Stage III, dead, 590 days 2032.7
TCGA-GU-A767-01A 81 years, male, white, stage:Stage IV, dead, 144 days 2023.1
TCGA-XF-A9SJ-01A 83 years, male, white, stage:Stage IV, dead, 98 days 2013.0
TCGA-CU-A72E-01A 76 years, male, white, stage:Stage IV, dead, 413 days 1999.6
TCGA-FD-A3B6-01A 75 years, male, white, stage:Stage II, dead, 1005 days 1985.2
TCGA-E7-A97P-01A 73 years, male, asian, stage:Stage II, dead, 437 days 1978.0
TCGA-XF-A9SK-01A 65 years, male, white, stage:Stage IV, dead, 486 days 1975.8
TCGA-GU-A42P-01A 72 years, male, white, stage:Stage IV, dead, 332 days 1968.1
TCGA-FD-A5BT-01A 84 years, male, white, stage:Stage III, dead, 328 days 1967.5
TCGA-CU-A0YO-01A 84 years, male, white, stage:Stage IV, dead, 149 days 1944.4
TCGA-FD-A6TI-01A 73 years, male, white, stage:Stage IV, dead, 294 days 1939.3
TCGA-BT-A2LD-01A 78 years, female, white, stage:Stage IV, dead, 623 days 1935.4
TCGA-FD-A6TG-01A 73 years, male, white, stage:Stage IV, dead, 93 days 1923.5
TCGA-BT-A3PH-01A 76 years, male, white, stage:Stage IV, dead, 142 days 1922.1
TCGA-XF-A9SX-01A 63 years, female, white, stage:Stage IV, dead, 719 days 1908.4
TCGA-XF-A9SW-01A 85 years, male, white, stage:Stage IV, dead, 362 days 1881.8
TCGA-XF-A8HI-01A 57 years, female, white, stage:Stage IV, dead, 544 days 1867.8
TCGA-XF-AAN7-01A 60 years, male, white, stage:Stage IV, dead, 565 days 1838.2
TCGA-G2-A3IB-01A 66 years, male, black or african american, stage:Stage II, dead, 220 days 1833.9
TCGA-DK-A3IU-01A 58 years, male, white, stage:Stage II, dead, 706 days 1804.8
TCGA-GU-A42R-01A 68 years, male, white, stage:Stage IV, dead, 577 days 1798.6
TCGA-E7-A541-01A 66 years, male, white, stage:Stage II, dead, 778 days 1797.4
TCGA-FD-A62P-01A 76 years, male, white, stage:Stage II, dead, 191 days 1794.6
TCGA-CU-A0YR-01A 83 years, male, white, stage:Stage IV, dead, 460 days 1784.6
TCGA-G2-A2EL-01A 77 years, male, white, stage:Stage II, dead, 819 days 1712.3
TCGA-CF-A9FL-01A 85 years, male, asian, stage:Stage III, dead, 565 days 1710.8
TCGA-XF-A9SV-01A 82 years, male, white, stage:Stage IV, dead, 388 days 1675.3
TCGA-FD-A3SO-01A 68 years, male, white, stage:Stage IV, dead, 168 days 1669.1
TCGA-HQ-A5NE-01A 57 years, male, stage:Stage III, dead, 370 days 1626.5
TCGA-ZF-AA52-01A 70 years, male, white, stage:Stage III, dead, 1077 days 1614.5
TCGA-GU-AATO-01A 75 years, male, white, stage:Stage IV, dead, 324 days 1603.7
TCGA-ZF-AA4R-01A 67 years, male, white, stage:Stage IV, dead, 1036 days 1572.5
TCGA-FD-A3SR-01A 68 years, male, white, stage:Stage IV, dead, 602 days 1555.3
TCGA-FD-A3SS-01A 66 years, male, white, stage:Stage IV, dead, 391 days 1551.0
TCGA-4Z-AA81-01A 80 years, male, white, stage:Stage II, dead, 1270 days 1531.4
TCGA-E5-A4TZ-01A 64 years, male, white, stage:Stage IV, dead, 467 days 1517.1
TCGA-XF-A9T2-01A 54 years, male, white, stage:Stage III, dead, 575 days 1489.4
TCGA-XF-A9SL-01A 69 years, male, white, stage:Stage IV, dead, 2020 days 1464.4
TCGA-4Z-AA7R-01A 73 years, male, black or african american, stage:Stage IV, dead, 522 days 1455.7
TCGA-FD-A3SQ-01A 62 years, male, white, stage:Stage IV, dead, 1423 days 1450.8
TCGA-ZF-A9R0-01A 82 years, male, white, stage:Stage III, dead, 680 days 1448.8
TCGA-YC-A9TC-01A 71 years, male, white, stage:Stage IV, dead, 20 days 1442.3
TCGA-E7-A3X6-01A 70 years, male, white, stage:Stage II, dead, 904 days 1440.1
TCGA-K4-A4AC-01A 83 years, male, white, stage:Stage II, dead, 278 days 1425.6
TCGA-FD-A3N5-01A 69 years, male, black or african american, stage:Stage II, dead, 685 days 1413.8
TCGA-BT-A20U-01A 70 years, female, white, stage:Stage III, dead, 455 days 1387.1
TCGA-BT-A0YX-01A 70 years, female, white, stage:Stage III, dead, 400 days 1372.1
TCGA-DK-A2HX-01A 80 years, female, white, stage:Stage IV, dead, 1420 days 1366.8
TCGA-XF-A9T8-01A 64 years, male, white, stage:Stage III, dead, 418 days 1350.1
TCGA-FD-A3B3-01A 74 years, female, white, stage:Stage III, dead, 974 days 1330.9
TCGA-SY-A9G0-01A 82 years, male, white, stage:Stage IV, dead, 1008 days 1308.1
TCGA-4Z-AA80-01A 73 years, male, white, stage:Stage II, dead, 19 days 1298.6
TCGA-XF-AAMZ-01A 81 years, female, white, stage:Stage IV, dead, 1348 days 1289.8
TCGA-XF-AAN4-01A 77 years, female, white, stage:Stage III, dead, 823 days 1256.8
TCGA-ZF-AA4T-01A 65 years, male, white, stage:Stage IV, dead, 599 days 1256.1
TCGA-XF-AAME-01A 64 years, female, white, stage:Stage II, dead, 2828 days 1250.5
TCGA-BL-A3JM-01A 62 years, male, white, stage:Stage III, dead, 205 days 1219.2
TCGA-DK-A3IL-01A 79 years, female, white, stage:Stage IV, dead, 413 days 1198.6
TCGA-XF-AAMX-01A 87 years, female, black or african american, stage:Stage III, dead, 206 days 1177.6
TCGA-FD-A5C0-01A 61 years, male, white, stage:Stage IV, dead, 550 days 1170.9
TCGA-DK-A3IK-01A 87 years, male, white, stage:Stage IV, dead, 146 days 1168.0
TCGA-BT-A2LB-01A 73 years, female, white, stage:Stage III, dead, 492 days 1166.2
TCGA-DK-A1AB-01A 74 years, female, white, stage:Stage IV, dead, 508 days 1166.0
TCGA-BT-A20O-01A 75 years, male, white, stage:Stage III, dead, 370 days 1148.9
TCGA-FD-A3SM-01A 70 years, male, white, stage:Stage IV, dead, 547 days 1136.1
TCGA-BL-A13I-01A 57 years, female, white, stage:Stage III, dead, 223 days 1104.4
TCGA-DK-AA6L-01A 48 years, male, white, stage:Stage IV, dead, 1163 days 1072.7
TCGA-G2-A3IE-01A 51 years, male, white, stage:Stage II, dead, 612 days 1047.9
TCGA-DK-A1A5-01A 79 years, male, white, stage:Stage II, dead, 65 days 1034.1
TCGA-4Z-AA7S-01A 66 years, male, black or african american, stage:Stage III, dead, 1064 days 1033.9
TCGA-BT-A20T-01A 63 years, male, white, stage:Stage IV, dead, 453 days 1026.2
TCGA-FD-A3SL-01A 60 years, male, white, stage:Stage IV, dead, 712 days 998.4
TCGA-ZF-A9R9-01A 58 years, male, white, stage:Stage IV, dead, 864 days 988.3
TCGA-DK-A3IN-01A 72 years, male, white, stage:Stage III, dead, 250 days 914.0
TCGA-FD-A5BZ-01A 77 years, female, white, stage:Stage IV, dead, 835 days 776.6
TCGA-DK-A3X2-01A 85 years, male, white, stage:Stage IV, dead, 547 days 774.8
TCGA-XF-AAMJ-01A 70 years, male, asian, stage:Stage III, dead, 1670 days 693.3
TCGA-GC-A3I6-01A 45 years, male, white, stage:Stage III, dead, 630 days 689.9
TCGA-FD-A62S-01A 60 years, female, black or african american, stage:Stage III, dead, 406 days 671.1
TCGA-ZF-A9RE-01A 78 years, female, white, stage:Stage II, dead, 106 days 615.0
Show allShow less
UROTHELIAL CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA052543
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Urothelial carcinoma, High grade
Urothelial carcinoma, Low grade
Urothelial carcinoma, NOS

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org